Jorey Chernett, identified in regulatory filings as a 10% owner of Airsculpt Technologies, Inc. (NASDAQ:AIRS), bought 45,600 shares of the company's common stock on March 6, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The purchases were executed in multiple trades at prices that ranged from $1.96 to $2.09 per share, producing a weighted average price of $2.00. The combined cost of the transactions totaled $91,200. Following these acquisitions, Chernett directly holds 6,398,211 shares of Airsculpt Technologies.
The stock was trading at $2.09 at the time the filing was noted, a price level close to its 52-week low of $1.51. Despite the proximity to that low, the share price has climbed 22% over the last week.
Third-party analysis cited in the filing indicates a Fair Value estimate of $2.36 for the shares. The company’s equity has exhibited sizable volatility, reflected in a beta of 2.8. Financial metrics disclosed alongside the transaction show the business remains unprofitable and has experienced a 17% decline in revenue over the past twelve months.
Investors interested in further analysis are directed to the platform referenced in the filing, which provides a Pro Research Report and six additional ProTips for the ticker AIRS.
Summary
Jorey Chernett increased direct ownership of Airsculpt Technologies by purchasing 45,600 shares for $91,200 at an average price of $2.00 per share on March 6, 2026, bringing direct holdings to 6,398,211 shares, according to a Form 4 filing. The stock trades near its 52-week low while showing a recent one-week gain and an external Fair Value estimate above the current trading price.
Key points
- Chernett purchased 45,600 shares at a weighted average price of $2.00, in transactions priced between $1.96 and $2.09, totaling $91,200.
- After the trades, direct ownership stands at 6,398,211 shares of Airsculpt Technologies (NASDAQ:AIRS).
- Market data in the filing show the stock trading at $2.09, near a 52-week low of $1.51, but up 22% over the past week; external analysis lists a Fair Value of $2.36 and reports heightened volatility with a beta of 2.8.
Risks and uncertainties
- High price volatility - The stock’s beta of 2.8 signals substantial market sensitivity and potential price swings that can affect investors in small-cap equities and speculative holdings.
- Operating performance - The company remains unprofitable and reported a 17% decline in revenue over the last twelve months, reflecting business and financial risks for equity holders.
- Valuation and low trading levels - Shares are trading close to a 52-week low, which may reflect market concerns about near-term prospects despite a recent uptick in price.